1. Expert Working Group for the Canadian Guidelines on Sexually Transmitted Infections. Chlamydial infections. In: Wong T, Latham-Carmanico C, eds. Canadian Guidelines on Sexually Transmitted Infections. Ottawa: Public Health Agency of Canada, 2010.
Available at:

2. Hill A. Indifferent reporting of notifiable diseases. Canadian Medical Association Journal 2012; 184(10): E513-4.

3. Friedman SM, Sommersall L-A, Gardam M, et al. Suboptimal reporting of notifiable diseases in Canadian emergency departments: A survey of emergency physician knowledge, practices, and perceived barriers. Canadian Communicable Disease Report 2006; 32(17).
Available at:

4. McKay A, Barrett M. Rising reported rates of chlamydia among young women in Canada: What do they tell us about trends in the actual prevalence of the infection? Canadian Journal of Human Sexuality 2008; 17(1-2): 61-9.

5. Public Health Agency of Canada. Report on Sexually Transmitted Infections in Canada: 2008. Ottawa: Public Health Agency of Canada, 2010.
Available at:

6. Lemstra M, Neudorf C, Opondo J, et al. Epidemiological analysis of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Saskatoon Health Region. Canadian Journal of Public Health 2007; 98(2):  134-7.

7. Shields SA, Wong T, Mann J, et al.  Prevalence and correlates of chlamydia infection in Canadian street youth.  Journal of Adolescent Health 2004; 34: 384-90.

8. Gottlieb S, Ndowa F. Herpes simplex. In: Heymann D, ed.. Control of Communicable Diseases Manual. 19th Edition. Washington, DC: American Public Health Association, 2008: 300-4.

9. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bulletin of the World Health Organization 2008; 86(10): 805-12.

10. Singh AE, Romanowski B, Wong T, et al. Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sexually Transmitted Diseases 2005; 32(2): 95-100.

11. Howard M, Sellors JW, Jang D, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. Journal of Clinical Microbiology 2003; 41(1): 84-9.

12. Patrick DM, Dawar M, Cook DA, et al. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sexually Transmitted Diseases 2001; 28(7): 424-8.

13. Steenbeek A, Tyndall M, Sheps S, et al. An epidemiological survey of chlamydial and gonococcal infections in a Canadian Arctic community. Sexually Transmitted Diseases 2009; 36(2): 79-83.

14. Public Health Agency of Canada. Sexually Transmitted Infections in Canadian Street Youth—Findings from Enhanced Surveillance of Canadian Street Youth, 1999-2003. Ottawa: Public Health Agency of Canada, 2006.
Available at:

15. Aslam M, Kropp RY, Jayaraman G, et al. Genital herpes in Canada: Deciphering the hidden epidemic. Canadian Journal of Infectious Disease in Medicine and Microbiology 2012; 23(1): e6-9.

16. Forward KR, Lee SHS.  Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. Canadian Journal of Infectious Diseases 2003; 14(2): 94-6.

17. Gilbert M, Li X, Petric M, et al. Using centralized laboratory data to monitor trends in Herpes Simplex Virus Type 1 and 2 Infection in British Columbia and the changing etiology of genital herpes. Canadian Journal of Public Health 2011; 102(3): 225-9.

18. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually  Transmitted Infections 1999; 75(1): 3-17.

19. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. The Journal of Infectious Diseases 2002; 185: 45-52.

20. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.

21. Paavonen J, Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm W, et al., eds. Sexually Transmitted Diseases. Fourth Edition. New York: McGraw-Hill Medical, 2008: 1017-50.

22. Land JA, Van Bergen JEAM, Morré SA, et al. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Human Reproduction Update 2010; 16(2): 189-204.

23. Rours GIJG, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. European Journal of Epidemiology 2011; 26: 493-502.

24. Johnson R, Ndowa F. Chlamydial infections. In: Heymann D, ed. Control of Communicable Diseases Manual. 19th Edition. Washington, DC: American Public Health Association, 2008: 116-9.

25. Rours GIJG, Hammerschlag MR, Ott A, et al. Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics 2008; 121(2): e321-6.

26. Rours GIJG, Hammerschlag MR, Van Doornum GJJ, et al. Chlamydia trachomatis respiratory infection in Dutch infants. Archives of Disease in Childhood 2009; 94(9): 705-7.

27. Kimberlin DW. Herpes simplex virus infections of the newborn. Seminars in Perinatology 2007; 21: 19-25.

28. Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006 ; 117(6): 1955-62.

29. Statistics Canada. Canadian Health Measures Survey (CHMS) Data User Guide: Cycle 2 April 2013.
Available at:

30. Day B, Langlois R, Tremblay M, Knoppers B-M. Canadian Health Measures Survey: ethical, legal and social issues. Health Reports 2007; 18(Suppl.): 37-51.

31. Tremblay M, Wolfson M, Connor Gorber S. Canadian Health Measures Survey: Rationale, background and overview.  Health Reports 2007; 18(Suppl.): 7-20.

32. Statistics Canada. Canadian Health Measures Survey (CHMS) Standard Operating Procedures for Laboratory Infection Markers: Cycle 2. 2012. Unpublished.

33. Loeffelholz MJ, Lewinski CA, Silver SR, et al. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. Journal of Clinical Microbiology 1992; (11): 2847-51.

34. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clinical Infectious Diseases 2002; 35(Suppl. 2): S173-8.

35. Ratnam S, Severini A, Zahariadis G, et al.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Canadian Journal of Infectious Diseases and Medical Microbiology 2007; 18(4): 233-40.

36. Rao JNK, Wu GFJ, Yue K. Some recent work on resampling methods for complex surveys. Survey Methodology 1992; 18(2): 209-17.

37. Rust KF, Rao JNK. Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research 1996; 5(3): 281-310.

38. Centers for Disease Control. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years—United States, 2005-2008. Morbidity and Mortality Weekly Report 2010; 59(15): 456-9.

39. Datta SD, Torrone E, Kruszon-Moran D, et al.  Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.  Sexually Transmitted Diseases 2012; 39(2):  92-6.

40. Cunningham AL, Taylor R, Taylor J, et al. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sexually Transmitted Infection 2006; 82(2): 164-8.

41. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behavior in Britain:  reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. The Lancet 2001; 358: 1851-4.

42. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. New England Journal of Medicine 1997; 337(16): 1105-11.

43. Bauer GR, Khobzi N, Coleman TA. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: A population-based analysis.  BMC Infectious Diseases 2010; 10: 359.

44. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Journal of the American Medical Association 2006; 296(8):  964-73.

45. Centers for Disease Control. Sexually Transmitted Infection Guidelines 2010. Diseases Characterized by Genital, Anal, or Perianal Ulcers. Atlanta, Georgia: Centers for Disease Control. Available at:

46. Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: The case for screening. Preventive Medicine 2003; 36(4): 502-9.

47. Bernstein DI, Bellamy AR, Hook EW 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clinical Infectious Diseases 2013; 56(3): 344-51.

48. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstetrica et Gynecologica Scandinavia 2000; 79(8): 693-6.